Research ArticleArticle
Selective time- and NADPH-dependent inhibition of human CYP2E1 by Clomethiazole
David M. Stresser, Elke S Perloff, Andrew K Mason, Andrew P Blanchard, Shangara S Dehal, Timothy P Creegan, Ritu Singh and Eric T Gangl
Drug Metabolism and Disposition May 5, 2016, dmd.116.070193; DOI: https://doi.org/10.1124/dmd.116.070193
David M. Stresser
1 Corning Life Sciences;
Elke S Perloff
2 BD Biosciences;
Andrew K Mason
2 BD Biosciences;
Andrew P Blanchard
2 BD Biosciences;
Shangara S Dehal
2 BD Biosciences;
Timothy P Creegan
1 Corning Life Sciences;
Ritu Singh
1 Corning Life Sciences;
Eric T Gangl
3 AstraZeneca
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Selective time- and NADPH-dependent inhibition of human CYP2E1 by Clomethiazole
David M. Stresser, Elke S Perloff, Andrew K Mason, Andrew P Blanchard, Shangara S Dehal, Timothy P Creegan, Ritu Singh and Eric T Gangl
Drug Metabolism and Disposition May 5, 2016, dmd.116.070193; DOI: https://doi.org/10.1124/dmd.116.070193
Research ArticleArticle
Selective time- and NADPH-dependent inhibition of human CYP2E1 by Clomethiazole
David M. Stresser, Elke S Perloff, Andrew K Mason, Andrew P Blanchard, Shangara S Dehal, Timothy P Creegan, Ritu Singh and Eric T Gangl
Drug Metabolism and Disposition May 5, 2016, dmd.116.070193; DOI: https://doi.org/10.1124/dmd.116.070193
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement